DKK 94.26
(-0.06%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 869 Million DKK | -21.78% |
2022 | 1.11 Billion DKK | -53.65% |
2021 | 2.39 Billion DKK | 47.33% |
2020 | 1.62 Billion DKK | -18.73% |
2019 | 2 Billion DKK | 11.47% |
2018 | 1.79 Billion DKK | 15.28% |
2017 | 1.55 Billion DKK | 7.82% |
2016 | 1.44 Billion DKK | 18.44% |
2015 | 1.22 Billion DKK | 2.09% |
2014 | 1.19 Billion DKK | 6.89% |
2013 | 1.11 Billion DKK | 111.74% |
2012 | 528 Million DKK | -57.96% |
2011 | 1.25 Billion DKK | -51.11% |
2010 | 2.56 Billion DKK | 5608.89% |
2009 | 45 Million DKK | -81.25% |
2008 | 240 Million DKK | -33.15% |
2007 | 359 Million DKK | 627.94% |
2006 | -68 Million DKK | -108.26% |
2005 | 823 Million DKK | 55.28% |
2004 | 530 Million DKK | 682.42% |
2003 | -91 Million DKK | -101.68% |
2002 | 5.42 Billion DKK | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 287 Million DKK | -37.72% |
2024 Q1 | 456 Million DKK | 157.63% |
2023 Q2 | 231 Million DKK | 230.0% |
2023 Q4 | 177 Million DKK | -54.73% |
2023 Q3 | 391 Million DKK | 69.26% |
2023 FY | 869 Million DKK | -21.78% |
2023 Q1 | 70 Million DKK | -88.12% |
2022 Q4 | 589 Million DKK | 61.81% |
2022 Q2 | 397 Million DKK | 561.63% |
2022 FY | 1.11 Billion DKK | -53.65% |
2022 Q3 | 364 Million DKK | -8.31% |
2022 Q1 | -86 Million DKK | -116.23% |
2021 FY | 2.39 Billion DKK | 47.33% |
2021 Q1 | 712 Million DKK | 37.72% |
2021 Q3 | 571 Million DKK | -2.23% |
2021 Q4 | 530 Million DKK | -7.18% |
2021 Q2 | 584 Million DKK | -17.98% |
2020 Q1 | 251 Million DKK | -52.73% |
2020 Q3 | 712 Million DKK | 1383.33% |
2020 Q4 | 517 Million DKK | -27.39% |
2020 Q2 | 48 Million DKK | -80.88% |
2020 FY | 1.62 Billion DKK | -18.73% |
2019 Q4 | 531 Million DKK | -22.93% |
2019 Q3 | 689 Million DKK | 47.54% |
2019 FY | 2 Billion DKK | 11.47% |
2019 Q2 | 467 Million DKK | 17.63% |
2019 Q1 | 397 Million DKK | -22.31% |
2018 Q2 | 415 Million DKK | 31.33% |
2018 Q4 | 511 Million DKK | 22.54% |
2018 FY | 1.79 Billion DKK | 15.28% |
2018 Q1 | 316 Million DKK | -43.06% |
2018 Q3 | 417 Million DKK | 0.48% |
2017 FY | 1.55 Billion DKK | 7.82% |
2017 Q2 | 346 Million DKK | 20.98% |
2017 Q4 | 555 Million DKK | 49.6% |
2017 Q3 | 371 Million DKK | 7.23% |
2017 Q1 | 286 Million DKK | -46.44% |
2016 Q4 | 534 Million DKK | 63.3% |
2016 FY | 1.44 Billion DKK | 18.44% |
2016 Q3 | 327 Million DKK | 2.51% |
2016 Q1 | 282 Million DKK | -42.68% |
2016 Q2 | 319 Million DKK | 13.12% |
2015 FY | 1.22 Billion DKK | 2.09% |
2015 Q4 | 492 Million DKK | 55.7% |
2015 Q3 | 316 Million DKK | 4.29% |
2015 Q2 | 303 Million DKK | 10.99% |
2015 Q1 | 273 Million DKK | -13.06% |
2014 Q1 | 243 Million DKK | 8.0% |
2014 FY | 1.19 Billion DKK | 6.89% |
2014 Q2 | 288 Million DKK | 18.52% |
2014 Q3 | 210 Million DKK | -27.08% |
2014 Q4 | 314 Million DKK | 49.52% |
2013 Q1 | 194 Million DKK | 373.17% |
2013 FY | 1.11 Billion DKK | 111.74% |
2013 Q4 | 225 Million DKK | -19.64% |
2013 Q3 | 280 Million DKK | 3.32% |
2013 Q2 | 271 Million DKK | 39.69% |
2012 Q3 | 150 Million DKK | 19.05% |
2012 Q4 | 41 Million DKK | -72.67% |
2012 FY | 528 Million DKK | -57.96% |
2012 Q1 | 144 Million DKK | -83.49% |
2012 Q2 | 126 Million DKK | -12.5% |
2011 Q3 | 167 Million DKK | -20.48% |
2011 Q2 | 210 Million DKK | 128.26% |
2011 Q1 | 92 Million DKK | -54.23% |
2011 FY | 1.25 Billion DKK | -51.11% |
2011 Q4 | 872 Million DKK | 422.16% |
2010 Q1 | 79 Million DKK | 315.79% |
2010 FY | 2.56 Billion DKK | 5608.89% |
2010 Q4 | 201 Million DKK | -90.79% |
2010 Q3 | 2.18 Billion DKK | 1959.43% |
2010 Q2 | 106 Million DKK | 34.18% |
2009 Q3 | 37 Million DKK | 208.33% |
2009 Q2 | 12 Million DKK | 118.46% |
2009 FY | 45 Million DKK | -81.25% |
2009 Q1 | -65 Million DKK | 0.0% |
2009 Q4 | 19 Million DKK | -48.65% |
2008 FY | 240 Million DKK | -33.15% |
2007 FY | 359 Million DKK | 627.94% |
2006 FY | -68 Million DKK | -108.26% |
2005 FY | 823 Million DKK | 55.28% |
2004 FY | 530 Million DKK | 682.42% |
2003 FY | -91 Million DKK | -101.68% |
2002 FY | 5.42 Billion DKK | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Ambu A/S | 645 Million DKK | -34.729% |
ChemoMetec A/S | 178.78 Million DKK | -386.067% |
Demant A/S | 4.14 Billion DKK | 79.05% |
Scandinavian Medical Solutions A/S | 16.62 Million DKK | -5126.551% |
ViroGates A/S | -12.56 Million DKK | 7016.037% |